ArticleCancers2022

Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma.

Nora Isberner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.